JP2006511212A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006511212A5 JP2006511212A5 JP2004544141A JP2004544141A JP2006511212A5 JP 2006511212 A5 JP2006511212 A5 JP 2006511212A5 JP 2004544141 A JP2004544141 A JP 2004544141A JP 2004544141 A JP2004544141 A JP 2004544141A JP 2006511212 A5 JP2006511212 A5 JP 2006511212A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- vector
- less
- promoter
- homology
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013598 vector Substances 0.000 claims 13
- 239000002245 particle Substances 0.000 claims 3
- 108090000623 proteins and genes Proteins 0.000 claims 3
- 108010002350 Interleukin-2 Proteins 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 150000007523 nucleic acids Chemical group 0.000 claims 2
- 102000002627 4-1BB Ligand Human genes 0.000 claims 1
- 108010082808 4-1BB Ligand Proteins 0.000 claims 1
- 108091026890 Coding region Proteins 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 1
- 230000000139 costimulatory effect Effects 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 230000003308 immunostimulating effect Effects 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 230000002601 intratumoral effect Effects 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000013603 viral vector Substances 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10248141A DE10248141B4 (de) | 2002-10-11 | 2002-10-11 | Nukleinsäuren und deren Verwendung für die Gentherapie |
| PCT/EP2003/011252 WO2004035799A2 (de) | 2002-10-11 | 2003-10-10 | Virale vektoren und deren verwendung für die gentherapie |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010192832A Division JP2011036251A (ja) | 2002-10-11 | 2010-08-30 | ウイルスベクターおよびその遺伝子治療のための使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006511212A JP2006511212A (ja) | 2006-04-06 |
| JP2006511212A5 true JP2006511212A5 (enExample) | 2006-11-24 |
| JP4615311B2 JP4615311B2 (ja) | 2011-01-19 |
Family
ID=32102775
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004544141A Expired - Fee Related JP4615311B2 (ja) | 2002-10-11 | 2003-10-10 | ウイルスベクターおよびその遺伝子治療のための使用 |
| JP2010192832A Pending JP2011036251A (ja) | 2002-10-11 | 2010-08-30 | ウイルスベクターおよびその遺伝子治療のための使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010192832A Pending JP2011036251A (ja) | 2002-10-11 | 2010-08-30 | ウイルスベクターおよびその遺伝子治療のための使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8067227B2 (enExample) |
| EP (1) | EP1556411B1 (enExample) |
| JP (2) | JP4615311B2 (enExample) |
| AU (1) | AU2003273983A1 (enExample) |
| CY (1) | CY1114777T1 (enExample) |
| DE (1) | DE10248141B4 (enExample) |
| DK (1) | DK1556411T3 (enExample) |
| ES (1) | ES2440951T3 (enExample) |
| PT (1) | PT1556411E (enExample) |
| SI (1) | SI1556411T1 (enExample) |
| WO (1) | WO2004035799A2 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004069272A2 (en) * | 2003-02-05 | 2004-08-19 | Movecare Ltd | Adjuvant combination for use in the immunization of a mamal comprising il2 and il12 |
| DE102005055128B4 (de) * | 2005-11-15 | 2015-04-02 | Universität Rostock | Viraler Vektor, dessen Verwendung zur Therapie von Leberzellkarzinomen und pharmazeutische Mittel umfassend den Vektor |
| CN102174479B (zh) * | 2011-03-02 | 2013-04-03 | 北京锤特生物科技有限公司 | 靶向性治疗人肿瘤的溶肿瘤腺病毒及其应用 |
| CA3101783C (en) | 2011-10-11 | 2023-01-31 | Universitat Zurich Prorektorat Mnw | Combination medicament comprising il-12 and an agent for blockade of t-cell inhibitory molecules for tumour therapy |
| US11951157B2 (en) | 2011-10-11 | 2024-04-09 | Universitat Zurich | Methods of treating malignant tumour with IL-12 and anti-PD-1 antibody |
| AU2016251687C1 (en) | 2015-04-22 | 2023-07-27 | CureVac SE | RNA containing composition for treatment of tumor diseases |
| WO2017106795A1 (en) * | 2015-12-18 | 2017-06-22 | Oncosec Medical Incorporated | Plasmid constructs for heterologous protein expression and methods of use |
| EP3211000B1 (en) | 2016-02-25 | 2019-01-30 | Provecs Medical GmbH | Novel immunostimulating vector system |
| KR102469450B1 (ko) | 2016-05-18 | 2022-11-22 | 모더나티엑스, 인크. | 인터류킨-12 (il12)를 코딩하는 폴리뉴클레오티드 및 그의 용도 |
| EP3589308A1 (en) | 2017-02-28 | 2020-01-08 | Sanofi | Therapeutic rna |
| CN110582300B (zh) | 2017-05-02 | 2024-08-02 | 尼克塔治疗公司 | 肿瘤免疫治疗性治疗方法 |
| CN111936622B (zh) * | 2018-01-19 | 2024-05-28 | 可隆生命科学株式会社 | 重组痘苗病毒和包含其的药物组合物 |
| US11230699B2 (en) * | 2020-01-28 | 2022-01-25 | Immunitybio, Inc. | Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptors |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5573764A (en) * | 1994-01-21 | 1996-11-12 | Genetics Institute, Inc. | Use of interleukin-12 to prevent graft versus host disease |
| WO2000041508A2 (en) | 1999-01-15 | 2000-07-20 | Mount Sinai School Of Medicine Of The City University Of New York | Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines |
| KR20020010206A (ko) * | 2000-07-27 | 2002-02-04 | 이시우 | 인터루킨 12와 보조활성인자 ｂ7.1 유전자를 함유하는ｄｎａ 벡터 및 이벡터가 도입된 항암 세포백신 |
| EP2336339A3 (en) * | 2000-09-25 | 2011-09-14 | The Regents of the University of Michigan | Production of viral vectors |
-
2002
- 2002-10-11 DE DE10248141A patent/DE10248141B4/de not_active Expired - Fee Related
-
2003
- 2003-10-10 AU AU2003273983A patent/AU2003273983A1/en not_active Abandoned
- 2003-10-10 PT PT37579513T patent/PT1556411E/pt unknown
- 2003-10-10 WO PCT/EP2003/011252 patent/WO2004035799A2/de not_active Ceased
- 2003-10-10 US US10/530,706 patent/US8067227B2/en not_active Expired - Fee Related
- 2003-10-10 SI SI200332329T patent/SI1556411T1/sl unknown
- 2003-10-10 EP EP03757951.3A patent/EP1556411B1/de not_active Expired - Lifetime
- 2003-10-10 DK DK03757951.3T patent/DK1556411T3/da active
- 2003-10-10 ES ES03757951.3T patent/ES2440951T3/es not_active Expired - Lifetime
- 2003-10-10 JP JP2004544141A patent/JP4615311B2/ja not_active Expired - Fee Related
-
2010
- 2010-08-30 JP JP2010192832A patent/JP2011036251A/ja active Pending
-
2013
- 2013-12-27 CY CY20131101171T patent/CY1114777T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006511212A5 (enExample) | ||
| JP2024054426A5 (enExample) | ||
| JP2010516252A5 (enExample) | ||
| JP2020520662A5 (enExample) | ||
| JP2020514286A5 (enExample) | ||
| JP2020531032A5 (enExample) | ||
| JP2018520997A5 (enExample) | ||
| JP2020517635A5 (enExample) | ||
| JP2016538885A5 (enExample) | ||
| JP2020510428A5 (enExample) | ||
| JP2016512683A5 (enExample) | ||
| JP2015057052A5 (enExample) | ||
| JP2017532966A5 (enExample) | ||
| JP2017512466A5 (enExample) | ||
| FI3906066T3 (fi) | Geeniterapiakonstrukteja wilsonin taudin hoitamiseksi | |
| JP2008541759A5 (enExample) | ||
| RU2018136611A (ru) | Генная терапия для лечения гемофилии a | |
| JP2010227101A5 (enExample) | ||
| JP2017537622A5 (enExample) | ||
| MX2020000221A (es) | Secuencias de aminoacidos y de acidos nucleicos de adenovirus de grandes simios no humanos, vectores que contienen las mismas y usos de las mismas. | |
| JP2009544318A5 (enExample) | ||
| JP2016513115A5 (enExample) | ||
| CA2461380A1 (en) | Hepatitis c virus vaccine | |
| JP2004501650A5 (enExample) | ||
| JP2023040219A5 (enExample) |